We are proud to expand our partnership with AstraZeneca in a multi-year collaboration aimed at optimizing clinical trials in oncology. By leveraging our AI-powered platforms, we’re working ...

AstraZeneca ( (AZN)) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. AstraZeneca is a global biopharmaceutical company focused on the ...

AstraZeneca shared the topline result from the placebo-controlled trial in a press release Tuesday. NF1 affects around 1.7 million people worldwide, with about 70% being adults, according to ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of lung cancer, a step that will delay the drug’s arrival on the ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on AstraZeneca (AZN – Research Report), with a price target of £105.00. The company’s shares opened ...

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine research and development ...

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid a probe that has battered the drugmaker’s share price. Chief ...

Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascots are bounding about the grounds in ...

AstraZeneca CEO Pascal Soriot argued that the company did not lose oversight. “You really cannot police 18,000 people from the headquarter,” Soriot said during a press call Tuesday ...

British drugmaker AstraZeneca increased its full-year sales outlook on booming demand for its cancer and rare-disease drugs, and said it plans to invest $3.5 billion in its U.S. business by the ...

CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Tuesday reported third-quarter earnings of $1.43 billion. On a per-share basis, the Cambridge, Britain-based ...

AstraZeneca has put a £450m investment in Britain under review in a stand-off with ministers over state aid. The drugs giant told The Telegraph that proposals to build a new vaccine factory in ...